Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Long Term Debt 2014–2025
Akebia Therapeutics Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Akebia Therapeutics Inc. long term debt for the quarter ending December 31, 2025 were 48.3M, a 24.70% increase year-over-year.
- Akebia Therapeutics Inc. long term debt for 2025 were 48.3M, a 24.70% increase from 2024.
- Akebia Therapeutics Inc. long term debt for 2024 were 38.7M, a 11.56% increase from 2023.
- Akebia Therapeutics Inc. long term debt for 2023 were 34.7M, a 47.51% decrease from 2022.
- Akebia Therapeutics Inc. long term debt for 2022 were 66.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Akebia Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $48 |
| 2024 | $39 |
| 2023 | $35 |
| 2022 | $66 |
| 2021 | $98 |
| 2020 | $96 |
| 2019 | $76 |
| Akebia Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $48 |
| 2024-12-31 | $39 |
| 2023-12-31 | $35 |
| 2022-12-31 | $66 |
| 2021-12-31 | $98 |
| 2020-12-31 | $96 |
| 2019-12-31 | $76 |
Akebia Therapeutics Inc. Long Term Debt — FAQ
Akebia Therapeutics Inc. (AKBA) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's long term debt history?
The chart and table above show Akebia Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.